Le Lézard
Classified in: Health
Subjects: HEALTH, LIFESTYLE, MISCELLANEOUS, MISCELLANEOUS

Habitat for Humanity GTA Women Build Returns to Durham Region


Oshawa, June 07, 2022 (GLOBE NEWSWIRE) -- Habitat for Humanity Greater Toronto Area (Habitat GTA) volunteers, staff, supporters and future homeowners gathered to launch Women Build Durham 2022 today in Oshawa. This is the first time Habitat GTA has held the annual event since the pandemic began two years ago. Women Build is a one-of-a-kind fundraiser that invites women and friends to put on a construction hat, receive training and then help build affordable homes for local families.

"We are thrilled to be back in Durham Region with women rolling up their sleeves, grabbing a hammer and helping to build homes for local families," said Habitat GTA CEO Ene Underwood. "Many of the essential workers who helped get us through the pandemic are now struggling to find a quality home they can afford, especially in Oshawa where home prices have nearly doubled since the start of the pandemic."

Those who participate in Women Build Durham 2022 will help build the first 18 Habitat Homes that will be part of a new 50-unit affordable housing community. It's expected the first homes will be ready for families to move in starting in spring 2023. In addition, a portion of these homes will be provided to the BlackNorth Initiative, a new local non-profit committed to the removal of systemic barriers negatively affecting the lives of Black Canadians.

Habitat GTA is currently accepting applications for local families interested in becoming Habitat Homeowners in Oshawa at 485 Normandy. Those who are interested in learning more are encouraged to visit our website.

Habitat for Humanity GTA Women Build Durham 2022 runs June 7-11 at 485 Normandy St.

Attachments



These press releases may also interest you

at 08:05
Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced additional favorable safety and efficacy data from the company's ongoing Phase 1b/2 clinical trial...

at 08:05
Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, and AmplifyBio, a rapidly growing contract development and manufacturing organization, today announced the launch of a...

at 08:05
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced upcoming presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Illinois...

at 08:05
Kiromic BioPharma, Inc. ("Kiromic" or the "Company") announces that UPMC in Pittsburgh, Pennsylvania has been activated as the fourth clinical trial site in the Deltacel-01 Phase 1 trial evaluating Deltaceltm (KB-GDT-01), Kiromic's allogeneic,...

at 08:03
JPMA Cares, the nonprofit foundation of the juvenile products industry, announced it's launching a Safe Sleep Campaign in partnership with Cribs for Kids, First Candle, and Safe Kids Worldwide. The campaign aims to deliver easy-to-understand,...

at 08:00
MedISAO, an organization composed of members of the medical device manufacturer community dedicated to improving medical device security through education, awareness, and advocacy, announced today its endorsement by the Food and Drug Administration...



News published on and distributed by: